These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2485626)

  • 1. [Electroconvulsive therapy and its mechanism of action].
    Couvreur V; Ansseau M; Franck G
    Acta Psychiatr Belg; 1989; 89(1-2):96-109. PubMed ID: 2485626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of biochemical basis of the antidepressant action of electroconvulsive therapy by human studies.
    Mann JJ; Kapur S
    Psychopharmacol Bull; 1994; 30(3):445-53. PubMed ID: 7878181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiological correlates of the antidepressant action of electroconvulsive therapy.
    Mann JJ
    J ECT; 1998 Sep; 14(3):172-80. PubMed ID: 9773356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of action of electroconvulsive therapy in depression].
    Rios B; Vincente N
    Actas Esp Psiquiatr; 2001; 29(3):199-207. PubMed ID: 11412495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action.
    Sackeim HA; Decina P; Prohovnik I; Malitz S; Resor SR
    Biol Psychiatry; 1983 Nov; 18(11):1301-10. PubMed ID: 6317065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of a single electroconvulsive shock on pituitary-thyroid-adrenal-gonadal axis function in men with severe depression--preliminary report].
    Motta E; Ostrowska Z; Kazibutowska Z; Paluch M; Płonka J; Gołba A
    Psychiatr Pol; 2005; 39(3):469-79. PubMed ID: 16149757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptides and electroconvulsive treatment.
    Mathé AA
    J ECT; 1999 Mar; 15(1):60-75. PubMed ID: 10189619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of electroconvulsive therapy on mood, parkinsonism, and tardive dyskinesia in a depressed patient: ECT and dopamine systems.
    Holcomb HH; Sternberg DE; Heninger GR
    Biol Psychiatry; 1983 Aug; 18(8):865-73. PubMed ID: 6615944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine testing in electroconvulsive therapy.
    Kamil R; Joffe RT
    Psychiatr Clin North Am; 1991 Dec; 14(4):961-70. PubMed ID: 1771157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine hypothesis of antidepressant action of ECT.
    Fink M
    Psychopharmacol Bull; 1988; 24(3):400-2. PubMed ID: 3153500
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroendocrine aspects of the relief of melancholia by induced seizures (electroconvulsive treatment).
    Fink M
    Adv Biochem Psychopharmacol; 1984; 39():345-57. PubMed ID: 6205561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional neuroimaging of electroconvulsive therapy and transcranial magnetic stimulation.
    Nobler MS; Teneback CC; Nahas Z; Bohning DE; Shastri A; Kozel FA; George MS
    Depress Anxiety; 2000; 12(3):144-56. PubMed ID: 11126189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients.
    Fernandes B; Gama CS; Massuda R; Torres M; Camargo D; Kunz M; Belmonte-de-Abreu PS; Kapczinski F; de Almeida Fleck MP; Inês Lobato M
    Neurosci Lett; 2009 Apr; 453(3):195-8. PubMed ID: 19429034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroconvulsive therapy: present and future.
    Gomez GE
    Issues Ment Health Nurs; 2004; 25(5):473-86. PubMed ID: 15204891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electroconvulsive therapy in neurologic diseases].
    Folkerts H
    Nervenarzt; 1995 Apr; 66(4):241-51. PubMed ID: 7783810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study.
    Okamoto T; Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Inoue Y; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1185-90. PubMed ID: 18403081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electroconvulsive therapy in the treatment of Parkinson disease].
    Jeanneau A
    Encephale; 1993; 19(5):573-8. PubMed ID: 8306926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of electroconvulsive therapy in adolescents. A restrospective study].
    Hegeman JM; Doesborgh SJ; van Niel MC; van Megen HJ
    Tijdschr Psychiatr; 2008; 50(1):23-31. PubMed ID: 18188826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroconvulsive therapy in patients with multiple sclerosis.
    Rasmussen KG; Keegan BM
    J ECT; 2007 Sep; 23(3):179-80. PubMed ID: 17804994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological effects of electroconvulsive therapy and transcranial magnetic stimulation in major depression.
    Szuba MP; O'Reardon JP; Evans DL
    Depress Anxiety; 2000; 12(3):170-7. PubMed ID: 11126192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.